首页> 外国专利> Methods to prepare highly Purified gamma globulin, free of ineffectiveness with hepatitis B virus

Methods to prepare highly Purified gamma globulin, free of ineffectiveness with hepatitis B virus

机译:制备不含丙型肝炎病毒无效的高度纯化的丙种球蛋白的方法

摘要

The present Invention relates to a method to eliminate the infectivity of hepatitis B with a Fluid Body that contains gamma glubilina,Characterized in that it comprises the steps of: a) providing the body fluid containing gamma globulin to Purify; (b) Implement the body fluid to a First and a Second columnAs in series, The First Column containing an effective amount of a DEAE - Sepharose Resin that is Rigid or DEAE bio gel (High Capacity)And the second column contains an effective amount of a Resin which consists of Rigid or DEAE - sephandez qae - sephandex; (c) to elute the body fluid of the first column with a Regulator SetOr at least at a pH of 7.0 and the Regulator approximately 0.If the Regulator 02 m phosphate Resin was selected for the second cvolumna is qae - sephandex, consisting of approximately 0.04 or Regulator Regulator m tris, 0.05 m Regulator about 0.035 m imidazole.Regulator of sodium phosphate (Na2HPO4 - Citric Acid), if the selected resin to the second DEAE sephandez or sephandez volumna of QAE,(d) monitor the effluent containing Proteins (f) Implement the collected effluent containing Proteins, the first column to the second.(g) to elute the Fluid of the second column, with one of the Regulators can be used in the first column, with the Regulator to a pH of at least 7.0 being the Regulators used in the first and second columns, respectively.The same or different and (H) to collect the effluent of the second column so that it is now eliminated any ineffectiveness with the hepatitis B virus.
机译:本发明涉及一种消除含有丙种球蛋白的液体的乙型肝炎的传染性的方法,其特征在于它包括以下步骤:a)提供一种含有丙种球蛋白的体液进行纯化; (b)将体液注入第一列和第二列依次进行,第一列包含有效量的DEAE-琼脂糖树脂(刚性或DEAE生物凝胶)(高容量),第二列包含有效量的由刚性或DEAE组成的树脂-sephandez qae-sephandex; (c)用调节剂SetOr或至少在7.0的pH值下调节剂洗脱第一根柱子的体液,并且调节剂约为0.如果选择的调节剂02 m磷酸树脂用于第二个Cvolumna是qae-sephandex,大约由0.04或调节剂调节剂m tris,0.05 m调节剂约0.035 m咪唑。磷酸钠调节剂(Na2HPO4-柠檬酸),如果所选树脂是QAE的第二DEAE sephandez或sephandez volumna,(d)监测含蛋白质的废水( f)在第一列至第二列中使用收集的含有蛋白质的流出物。(g)用第二个色谱柱中的一种调节剂洗脱第二个色谱柱的流体,第一调节柱可使用pH至少为7.0是分别用于第一和第二列的调节剂。相同或不同,并且(H)收集第二列的流出物,从而消除了乙型肝炎病毒的任何无效性。

著录项

  • 公开/公告号MX166053B

    专利类型

  • 公开/公告日1992-12-16

    原文格式PDF

  • 申请/专利权人 JOHNSON & JOHNSON;

    申请/专利号MX19850026449

  • 申请日1985-12-10

  • 分类号A61K39/12;A61K39/12;C07K3/20;

  • 国家 MX

  • 入库时间 2022-08-22 05:11:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号